Jason Helfstein, Oppenheimer head of internet research, joins 'The Exchange' to discuss Spotify as the stock sinks on Q2 ...

Trump's trade deals with the EU and Japan pave the way for the stock market to end with it's third straight annual gain of ...

Oppenheimer Asset Management on Monday raised its year-end target for the S&P 500 index to 7,100, the highest among major ...

Sarepta Therapeutics ( NASDAQ: SRPT) was upgraded to Neutral from Underweight at J.P. Morgan as it sees FDA's Elevidys hold removal recommendation in ambulatory patients as a clear win.

Sarepta stock sees upgrades and price hikes as analysts reassess Elevidys prospects following a favorable FDA development.

Jensen Huang believes questions of whether artificial intelligence (AI) could destroy humanity are fear-mongering — and get ...

Analysts upgraded Carvana shares, arguing the company is a "digitally-driven disruptor" in the fractured used car market.

Oppenheimer analyst Brian Nagel sees upside in Carvana stock to $450. CVNA is set to report its fiscal second-quarter ...

Christopher Nolan’s Oppenheimer resurfaces on global streaming charts two years after release, trending in over 40 countries.

There are many hugely impressive things about the film – not least the central, Oscar-winning, performance from Cillian ...

Oppenheimer was first a brilliant scientist, then a war hero, then a political traitor, then a nobody, then a martyr, now a ...

The gaming platform's algorithm may help it identify popular concepts before competitors, as it did with 'Grow A Garden,' analysts said.